Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  550 results for ""Polycythemia Vera""

Your Filters

Subject : antineoplastic agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

  • Authors : Dam MJB; Center for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.; Pedersen RK

Subjects: Alleles* ; Blood Cell Count*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: European journal of haematology [Eur J Haematol] 2021 Dec; Vol. 107 (6), pp. 624-633. Date of Electronic Publication: 2021 Sep 30.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list
×
Academic Journal

[Novel therapeutics in myeloproliferative neoplasms: beyond JAK inhibitors].

  • Authors : Edahiro Y; Department of Hematology, Juntendo University School of Medicine.

Subjects: Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/therapeutic use ; Primary Myelofibrosis*/Primary Myelofibrosis*/Primary Myelofibrosis*/drug therapy ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics

  • Source: [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2023; Vol. 64 (9), pp. 970-980.Publisher: Japan Society Of Clinical Hematology Country of Publication: Japan NLM ID: 2984782R Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations.

  • Authors : Tan G; Functional Genomics Center Zurich, University and ETH Zurich, Zurich, Switzerland.; Meier-Abt F

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Hematopoietic Stem Cells/Hematopoietic Stem Cells/Hematopoietic Stem Cells/*drug effects ; Hydroxyurea/Hydroxyurea/Hydroxyurea/*pharmacology

  • Source: Experimental hematology [Exp Hematol] 2021 May; Vol. 97, pp. 47-56.e5. Date of Electronic Publication: 2021 Mar 04.Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics

  • Source: Leukemia [Leukemia] 2021 Feb; Vol. 35 (2), pp. 623-627. Date of Electronic Publication: 2020 May 05.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Novel Therapies in Polycythemia Vera.

  • Authors : Tremblay D; Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1079, New York, NY, 10029, USA.; Mascarenhas J

Subjects: Molecular Targeted Therapy*/Molecular Targeted Therapy*/Molecular Targeted Therapy*/adverse effects; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*drug therapy

  • Source: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2020 Apr; Vol. 15 (2), pp. 133-140.Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

  • Authors : Büyükaşık Y; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey; Ali R

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Hydroxyurea/Hydroxyurea/Hydroxyurea/*therapeutic use ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*drug therapy

  • Source: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2020 Aug 28; Vol. 37 (3), pp. 177-185. Date of Electronic Publication: 2020 Publisher: Galenos Yayinevi Country of Publication: Turkey NLM ID: 9606065 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms.

  • Authors : Choi HS; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.; Hong J

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Hydroxyurea/Hydroxyurea/Hydroxyurea/*therapeutic use ; Neoplasms, Second Primary/Neoplasms, Second Primary/Neoplasms, Second Primary/*etiology

  • Source: Annals of hematology [Ann Hematol] 2021 Oct; Vol. 100 (10), pp. 2567-2574. Date of Electronic Publication: 2021 Jul 30.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available.

  • Authors : Foltz L; St. Paul's Hospital, University of British Columbia, Vancouver, Canada.; Pica GM

Subjects: Salvage Therapy*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*drug effects

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (14), pp. 3493-3502. Date of Electronic Publication: 2019 Jul 30.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Oral idasanutlin in patients with polycythemia vera.

  • Authors : Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; Lu M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*drug therapy ; Pyrrolidines/Pyrrolidines/Pyrrolidines/*administration & dosage

  • Source: Blood [Blood] 2019 Aug 08; Vol. 134 (6), pp. 525-533. Date of Electronic Publication: 2019 Jun 05.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Running interferon interference in treating PV/ET: meeting unmet needs.

  • Authors : Traxler EA; Department of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Hexner EO

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Interferons/Interferons/Interferons/*therapeutic use ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*drug therapy

  • Source: Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2021 Dec 10; Vol. 2021 (1), pp. 463-468.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  550 results for ""Polycythemia Vera""